contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


brain-is-seeking-restructuring-proceedings

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Brain+ are a pharmaceutical company. The company specializes in research and development for the treatment of dementia and Alzheimer's. The product portfolio includes, for example, cognitive stimulation therapy. In addition to the main business, service and associated ancillary services are also offered. The business is run with the largest presence in Europe. Brain+ is headquartered in Copenhagen.

Brain+

COMPANY ANNOUNCEMENT NO. 2026-1Copenhagen, Denmark, 20 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)As previously announced on 19 November 2025, Brain+ A/S has been exploring various...

<p>COMPANY ANNOUNCEMENT NO. 2026-1</p><p><em>Copenhagen, Denmark, 20 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)</em></p><p>As previously announced on 19 November 2025, Brain+ A/S has been exploring various options to secure financing for the Company. Despite these efforts, the Company has not been able at this time to secure a long-term financing solution.</p><p>Accordingly, the Board of Directors has resolved to initiate a formal assessment of restructuring options and expects to submit a request for restructuring proceedings to the court today, Tuesday, 20 January 2026.</p><p>The purpose of the restructuring process is to evaluate available strategic alternatives, which may include continued operations under a restructuring framework, sale of the company’s assets to pay debt and the liquidation and delisting of the company, recapitalization or other value-preserving transactions. &nbsp;</p><p>During this process, the Company intends to continue its activities to the extent possible while working with its advisers to safeguard stakeholder interests.</p><p>The Company will keep the market informed of any further material developments in accordance with its disclosure obligations.</p><h3>For more information, please contact:</h3><p><strong>Devika Wood, CEO</strong>&nbsp;+44 7429 280366&nbsp;<a href="mailto:devika@brain-plus.com">devika@brain-plus.com</a></p><p><strong>Otto Rasmussen, CFO</strong>&nbsp;+45 5253 6886&nbsp;<a href="mailto:otto@brain-plus.com">otto@brain-plus.com</a></p><p><a href="http://www.brain-plus.com/">www.brain-plus.com</a></p><h3>Certified Adviser</h3><p><strong>HC Andersen Capital 2 ApS</strong>&nbsp;E-mail:&nbsp;<a href="mailto:ca@hcandersencapital.dk">ca@hcandersencapital.dk</a>&nbsp;<a href="http://www.hcandersencapital.dk/">www.hcandersencapital.dk</a></p><h3>About Brain+</h3><p>Brain+ A/S is a digital health company listed on Nasdaq First North Growth Market Denmark, building the world's first scalable dementia care platform. By reducing preparation time, standardising best practice, and supporting staff training, Ayla empowers healthcare professionals to provide more accessible, effective dementia treatment and care. The Company's flagship product, Ayla – your CST Assistant, is a digital tool designed to support the consistent delivery of Cognitive Stimulation Therapy (CST) — a non-pharmacological, NICE-recommended, and clinically proven therapy for people with mild to moderate dementia.</p>    <div>      <hr>      <div><strong>Attachments</strong></div>      <div><a href="https://storage.googleapis.com/inderes-widgets-prod-assets/brainplus/attachments/74fc9d01-0b33-45d2-99ae-dd16ccdc8b92/2026-0120-b-company-announcement-brain-is-seeking-restructuring-proceedings.pdf">2026-0120 B  Company Announcement_Brain  is seeking restructuring proceedings.pdf</a></div>    </div>